The Ministry of Health and Prevention “MOHAP” in the UAE launched the smart application about pharmacovigilance under the name “UAE RADR”. UAE RADR is used for the complete management of pharmacovigilance including WHO’s UPPSALA monitoring center on the side effects of drugs, guideline on good pharmacovigilance practices which features the procedures required from the marketing authorization holders for drugs and medical products to ensure the safe use of its products in the country.
MOHAP launched the App at Arab Health 2019, which is considered the largest exhibition for healthcare professionals in Middle East and North Africa. It witnessed the participation of 4250 exhibiting companies and more than 84500 visitors from 160 countries.
H.E Abdulrahman bin Mohamed Al Owais, Minister of Health and Prevention pointed out that building quality, curative, health and drug systems, in accordance with the international standards, are strategic goals for the ministry, thus the enhancement of pharmacovigilance and drug safety are a part and parcel of the ministry’s goals which strives to maintain patients’ safety and boosting the society prevention. Additionally, these programmes open the door to the communication with all society groups via simple, effective and smart online methods.
Dr. Al Amiri Assistant Undersecretary for Public Health Policy and Licensing of the Ministry of Health & Prevention and Chairman for Supreme Pharmacovigilance committee noted that the App allows pharmacovigilance officers to conduct studies and researches on the reports of the side-effects in an easy and automated way. Also, it gives them a chance to check the incoming reports from other countries, which help us take the precautionary measures when needed.